BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 23181996)

  • 1. Guillain-Barré syndrome and catecholamine therapy. A potential risk for developing takotsubo cardiomyopathy?
    Quick S; Quick C; Schneider R; Sveric K; Katzke S; Strasser RH; Ibrahim K
    Int J Cardiol; 2013 May; 165(3):e43-4. PubMed ID: 23181996
    [No Abstract]   [Full Text] [Related]  

  • 2. Takotsubo cardiomyopathy associated with Guillain-Barré syndrome: a differential diagnosis from dysautonomia not to be missed.
    Martins RP; Barbarot N; Coquerel N; Baruteau AE; Kolev I; Vérin M
    J Neurol Sci; 2010 Apr; 291(1-2):100-2. PubMed ID: 20117795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversible stress cardiomyopathy in Guillain-Barré syndrome: a case report.
    Gravos A; Destounis A; Katsifa K; Tselioti P; Sakellaridis K; Grammatikopoulou V; Tsapas C; Nodarou A; Batiani P; Prekates A
    J Med Case Rep; 2019 May; 13(1):150. PubMed ID: 31104633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A rare stress cardiomyopathy in a patient with Guillain-Barré syndrome.
    Boon M; Dennesen PJ; Veldkamp RF
    Neth J Med; 2016 Feb; 74(2):86-8. PubMed ID: 26951354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolated right ventricular Takotsubo cardiomyopathy in Guillain-Barré syndrome.
    Song X; Chi C; Song J; Zhu J
    BMC Cardiovasc Disord; 2022 Dec; 22(1):531. PubMed ID: 36476210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Head injury and inverted Takotsubo cardiomyopathy.
    Riera M; Llompart-Pou JA; Carrillo A; Blanco C
    J Trauma; 2010 Jan; 68(1):E13-5. PubMed ID: 19065115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug-Induced Takotsubo Cardiomyopathy.
    Kido K; Guglin M
    J Cardiovasc Pharmacol Ther; 2017 Nov; 22(6):552-563. PubMed ID: 28490198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Takotsubo syndrome triggered by acute intermittent porphyria attack: An unusual stressor for catecholamine-induced cardiomyopathy.
    Messas N; Willemain R; Bilger A; Rondeau-Lutz M; Kuhnert C; Mertes PM; Morel O; Collange O
    Int J Cardiol; 2016 Mar; 207():28-30. PubMed ID: 26788817
    [No Abstract]   [Full Text] [Related]  

  • 9. Epinephrine administration and Takotsubo syndrome: Lessons from past experiences.
    Madias JE
    Int J Cardiol; 2016 Mar; 207():100-2. PubMed ID: 26800126
    [No Abstract]   [Full Text] [Related]  

  • 10. Reverse Takotsubo cardiomyopathy in the setting of anaphylaxis treated with high-dose intravenous epinephrine.
    Khoueiry G; Abi Rafeh N; Azab B; Markman E; Waked A; AbouRjaili G; Shariff M; Costantino T
    J Emerg Med; 2013 Jan; 44(1):96-9. PubMed ID: 22595633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Basal stress cardiomyopathy induced by exogenous catecholamines in younger adults.
    Fulcher J; Wilcox I
    Int J Cardiol; 2013 Oct; 168(6):e158-60. PubMed ID: 24035176
    [No Abstract]   [Full Text] [Related]  

  • 12. Drug-induced takotsubo cardiomyopathy.
    Izumi Y
    Heart Fail Clin; 2013 Apr; 9(2):225-31, ix-x. PubMed ID: 23562123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stress-induced cardiomyopathy in a patient with chronic spinal cord transection at the level of C5: endocrinologically mediated catecholamine toxicity.
    Redfors B; Shao Y; Omerovic E
    Int J Cardiol; 2012 Sep; 159(3):e61-2. PubMed ID: 22240764
    [No Abstract]   [Full Text] [Related]  

  • 14. More takotsubo syndrome in Guillain-Barré syndrome.
    Finsterer J; Frank M
    Neth J Med; 2016 Aug; 74(7):322-3. PubMed ID: 27571954
    [No Abstract]   [Full Text] [Related]  

  • 15. Danger to the ventricular myocardium from prolonged ablation procedures combined with a long-lasting catecholamine infusion for provocative arrhythmia testing.
    Farré J; Ibañez B
    Europace; 2008 Dec; 10(12):1361-2. PubMed ID: 18845563
    [No Abstract]   [Full Text] [Related]  

  • 16. 'Hyperacute' Guillain-Barré syndrome.
    Steiner I; Wirguin I; Blumen SC; Dano M; Raphaeli G; Schwartz I; Korn-Lubetzki I
    Eur Neurol; 2008; 59(1-2):88-90. PubMed ID: 17934279
    [No Abstract]   [Full Text] [Related]  

  • 17. Guillain-Barré syndrome in elderly people.
    Leung SS
    J Am Geriatr Soc; 2008 Feb; 56(2):381-2. PubMed ID: 18251836
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunoglobulin for concurrent Guillain-Barré and immune thrombocytopenic purpura.
    Zeidman LA; Fahey CD; Grinblatt DL; Harsanyi K
    Pediatr Neurol; 2006 Jan; 34(1):60-2. PubMed ID: 16376282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A rare form of Guillain-Barré syndrome: pharyngeal-cervical-brachial variant.
    Hergüner MO; Tepe T; Altunbaşak S; Baytok V
    Turk J Pediatr; 2008; 50(1):91-3. PubMed ID: 18365602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guillain-Barré syndrome complicated by takotsubo cardiomyopathy: an under-recognised association.
    Jones T; Umaskanth N; De Boisanger J; Penn H
    BMJ Case Rep; 2020 Feb; 13(2):. PubMed ID: 32060115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.